VENTOLIN EVOHALER Irlanda - inglês - HPRA (Health Products Regulatory Authority)

ventolin evohaler

primecrown ltd. - salbutamol sulfate - pressurised inhalation suspension - 100 microgram

VENTOLIN EVOHALER Irlanda - inglês - HPRA (Health Products Regulatory Authority)

ventolin evohaler

pco manufacturing - salbutamol - pressurised inhalation suspension - 100 microgram

VENTOLIN EVOHALER Irlanda - inglês - HPRA (Health Products Regulatory Authority)

ventolin evohaler

g & a licensing limited - salbutamol sulfate - pressurised inhalation suspension - 100 microgram

VENTOLIN EVOHALER Irlanda - inglês - HPRA (Health Products Regulatory Authority)

ventolin evohaler

mcdowell pharmaceuticals - salbutamol - pressurised inhalation suspension - 100 microgram

VENTOLIN EVOHALER Irlanda - inglês - HPRA (Health Products Regulatory Authority)

ventolin evohaler

profind wholesale ltd. - salbutamol - pressurised inhalation suspension - 100 microgram

Ventolin Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

ventolin

glaxosmithkline nz limited - salbutamol 100ug (micronised) - aerosol inhaler, metered dose - 100 mcg/dose - active: salbutamol 100ug (micronised) excipient: dichlorodifluoromethane oleic acid trichlorofluoromethane

VENTOLIN NEBULES 2.5 mg2.5 ml Cingapura - inglês - HSA (Health Sciences Authority)

ventolin nebules 2.5 mg2.5 ml

glaxosmithkline pte ltd - salbutamol sulphate eqv salbutamol - solution - 2.5 mg - salbutamol sulphate eqv salbutamol 2.5 mg

Ventolin Syrup Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

ventolin syrup

glaxosmithkline nz limited - salbutamol sulfate 0.48 mg/ml equivalent to 0.4 mg/ml salbutamol (or 2 mg salbutamol per 5 ml);   - syrup - 2 mg/5ml - active: salbutamol sulfate 0.48 mg/ml equivalent to 0.4 mg/ml salbutamol (or 2 mg salbutamol per 5 ml)   excipient: citric acid monohydrate hypromellose orange flavour 17-42-8187 purified water saccharin sodium sodium benzoate sodium chloride sodium citrate dihydrate - ventolin syrup is indicated for the treatment or prevention of bronchospasm. it provides short acting bronchodilation in reversible airways obstruction due to asthma, chronic bronchitis and emphysema. bronchodilators should not be the only or main treatment in patients with persistent asthma. in patients with persistent asthma unresponsive to salbutamol, treatment with inhaled corticosteroids is recommended to achieve and maintain control. failing to respond to treatment with salbutamol may signal a need for urgent medical advice or treatment. ventolin syrup is suitable oral therapy for children or those adults who prefer liquid medicines.

VENTOLIN NEBULES P.F. - 2.5MG/2.5ML SOLUTION Canadá - inglês - Health Canada

ventolin nebules p.f. - 2.5mg/2.5ml solution

glaxosmithkline inc - salbutamol (salbutamol sulfate) - solution - 2.5mg - salbutamol (salbutamol sulfate) 2.5mg - selective beta 2-adrenergic agonists

VENTOLIN NEBULES P.F. - 5MG/2.5ML SOLUTION Canadá - inglês - Health Canada

ventolin nebules p.f. - 5mg/2.5ml solution

glaxosmithkline inc - salbutamol (salbutamol sulfate) - solution - 5mg - salbutamol (salbutamol sulfate) 5mg - selective beta 2-adrenergic agonists